Cargando…
SARS-CoV-2 Inhibitors from Nigella Sativa
The recently encountered severe acute respiratory syndrome coronavirus 2 creates huge predicaments among various countries. Lack of specific treatment of COVID-19 disease demands urgency in drug design against SARS-CoV-2 targets. Nigella sativa the miraculous herb native to South and Southwest Asia...
Autores principales: | Baig, Asma, Srinivasan, Hemalatha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803537/ https://www.ncbi.nlm.nih.gov/pubmed/35102539 http://dx.doi.org/10.1007/s12010-021-03790-8 |
Ejemplares similares
-
In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets
por: Duru, Chidi Edbert, et al.
Publicado: (2021) -
Identification of SARS-CoV-2 RNA-dependent RNA polymerase inhibitors from the major phytochemicals of Nigella sativa: An in silico approach
por: Mir, Shabir Ahmad, et al.
Publicado: (2022) -
In vitro potential antiviral SARS-CoV-19- activity of natural product thymohydroquinone and dithymoquinone from Nigella sativa
por: Esharkawy, Eman R., et al.
Publicado: (2022) -
Molecular Mechanisms of Nigella sativa- and Nigella sativa Exercise-Induced Cardiac Hypertrophy in Rats
por: Al Asoom, Lubna Ibrahim
Publicado: (2021) -
ANTI-CANCER ACTIVITY OF NIGELLA SATIVA
por: Salomi, M.J., et al.
Publicado: (1989)